|
|
||||||||
SHORT ARTICLE |
Naval Health Research Center, DoD Center for Deployment Health Research PO Box 85122, San Diego, CA 92186-5122, USA
Corresponding author: Dr S.K. Poddar (e-mail: poddar{at}nhrc.navy.mil).
Received 19 June 2000; revised version accepted 2 Nov. 2000.
Abstract
This report describes a method for the isolation of nucleic acid from a suspension of matured virus. Nucleic acid (DNA) was isolated from a prototype strain of adenovirus type 7 and a clinical isolate of adenovirus type 7. Instead of the usual method of ultracentifugation, a filtration method was applied to concentrate the virus rapidly and nucleic acid was then isolated by a standard phenol/chloroform/isoamyl-alcohol extraction procedure. The DNA was found to be sufficiently purified to generate a reproducible restriction endonuclease digestion pattern. The clinical isolate of adenovirus type 7 revealed loss of restriction site for the endonuclease HindIII when compared with the prototype strain.
This article has been cited by other articles:
![]() |
A. Purkayastha, J. Su, J. McGraw, S. E. Ditty, T. L. Hadfield, J. Seto, K. L. Russell, C. Tibbetts, and D. Seto Genomic and Bioinformatics Analyses of HAdV-4vac and HAdV-7vac, Two Human Adenovirus (HAdV) Strains That Constituted Original Prophylaxis against HAdV-Related Acute Respiratory Disease, a Reemerging Epidemic Disease J. Clin. Microbiol., July 1, 2005; 43(7): 3083 - 3094. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Purkayastha, S. E. Ditty, J. Su, J. McGraw, T. L. Hadfield, C. Tibbetts, and D. Seto Genomic and Bioinformatics Analysis of HAdV-4, a Human Adenovirus Causing Acute Respiratory Disease: Implications for Gene Therapy and Vaccine Vector Development J. Virol., February 15, 2005; 79(4): 2559 - 2572. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |